Rocket


News + Filings
Transactions



Meyers Michael L.

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/15/2023Nuvalent, Inc. GrantStock Option (Right to Buy)15k$44.68$670.2k 06/15/2023
10/04/2022Nuvalent, Inc. GrantStock Option (Right to Buy)40k$19.48$779.2k 10/04/2022
12/30/2021Syndax Pharmaceuticals IncSNDXExerciseStock Options (Right to buy)5.9k$8.77$51.7k 12/30/2021
04/26/2021Syndax Pharmaceuticals IncSNDXPurchaseCommon Stock500$15.46$7.7k 04/26/2021
02/03/2021Syndax Pharmaceuticals IncSNDXGrantStock Option (Right to Buy)80k$21.36$1.7M 02/03/2021
01/31/2021Syndax Pharmaceuticals IncSNDXOther (acquisition)Common Stock1.8k$12.00$21.3k 02/03/2021
07/31/2020Syndax Pharmaceuticals IncSNDXOther (acquisition)Common Stock2.7k$7.97$21.2k 02/03/2021
03/21/2019Syndax Pharmaceuticals IncSNDXPurchaseCommon Stock104$4.87$506.5 03/21/2019
03/21/2019Syndax Pharmaceuticals IncSNDXPurchaseCommon Stock1000$4.93$4.9k 03/21/2019
03/21/2019Syndax Pharmaceuticals IncSNDXPurchaseCommon Stock8$4.87$39 03/21/2019
02/06/2019Syndax Pharmaceuticals IncSNDXGrantStock Option (Right to Buy)104.3k$6.38$665.6k 02/06/2019
01/31/2019Syndax Pharmaceuticals IncSNDXOther (acquisition)Common Stock3.7k$4.76$17.7k 02/06/2019
10/30/2018Syndax Pharmaceuticals IncSNDXPurchaseCommon Stock200$4.79$958 10/30/2018
03/01/2018Syndax Pharmaceuticals IncSNDXGrantStock Option (Right to Buy)75k$9.40$705k 03/01/2018
02/06/2017Syndax Pharmaceuticals IncSNDXGrantStock Option (Right to Buy)66.1k$8.77$579.7k 02/06/2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy